Tim

733 posts

Tim

Tim

@tim_pscl

Beigetreten Ağustos 2023
292 Folgt93 Follower
Angehefteter Tweet
Tim
Tim@tim_pscl·
$SOFI looking primed for a run? What do you think?
Tim tweet media
English
0
0
1
128
Tim
Tim@tim_pscl·
@stoicxtrades do you think we revisit 14-13$ ranfe before pump?
English
0
0
0
16
Stoic Trades
Stoic Trades@stoicxtrades·
$ZETA - the most simple chart out here📈 Wave 3 is active - target at $55 per share. Wave 4 pullback between $38 - $33. Wave 5 target at $65 - $82 | 320% growth from here.
Stoic Trades tweet media
English
1
0
0
216
Tim
Tim@tim_pscl·
@retail_mourinho I hope it finally gives me an entry opportunity
English
0
0
0
111
Retail Mourinho
Retail Mourinho@retail_mourinho·
Kraken Robotics $KRKNF 🦑 could became a great buying opportunity if it dips further
Retail Mourinho tweet media
English
3
2
77
6.1K
Serenity
Serenity@aleabitoreddit·
@tim_pscl $2-3B short term on $SIVE, just comparing it to counterparties that buy their lasers and repackage it at $1B-$3.8B+ Then if you look at CW laser suppliers, there's only a few in the world publicly traded that can do this.
English
2
0
40
4.3K
Serenity
Serenity@aleabitoreddit·
$SIVE at ~$400m MC is a name I genuinely believe... Institutions missed as the upstream laser chokepoint for hyperscalers. When you look at $TSEM following my thesis, the stock went up 70% to a $21B+ MC. Retail flows do not send NASDAQ stocks up $10B+. Information discovery and synthesis does. Especially when institutions validate it, and follow along. $SIVE was majority owned by Sweden retail investors, with **almost 0 institutional investors**. Now that information is distributed regarding the Upstream CW laser supplier for $MRVL, Ayar, Jabil, O-Net. And with $AVGO + other comments recently stating lasers were a clear bottleneck for supply chains: I strongly think that institutions are trying to accumulate off Swedish retail hands through Iceberg orders, vwap algos, or any other methods to gain exposure to the upcoming CW laser bottleneck. Again, the closest comparison to $SIVE are: $MTSI and $LITE, both at $18B and $55B MCs. Sivers trades at ~$400m MC. With architectural paradigm shifts in photonic supply chains: I think retail has a rare opportunity to frontrun institutions with $SIVE and have heavy exposure to the upcoming CW/EML laser bottleneck.
Serenity tweet media
English
32
70
446
52.7K
Tim retweetet
Ch🅰️rtradamus 🔋
Ch🅰️rtradamus 🔋@Chartradamus·
$ASTS Subwave 3 (of MW5) PT = $145 PW5 (of LTW3) PT = $162 🟢 "It does not want to lose $82" 🎯 Perfect. Bulls defended the level with strength off the much needed catalyst of a $2 Trillion SpaceX IPO looming on the horizon. This effectively re-rates the entire space sector higher. $ASTS is now breaking out over the downtrend line (yellow diagonal) respected since late January. This comes after tapping the .786 Fib ($82.50) of Subwave 2 in the current Minor Wave 5 structure. If able to confirm the move higher, Subwave 3 should take the stock towards its PT of $145, new ATHs. As long as the Volume POC with a range of $82-$88 holds, bulls are in control. We have now reclaimed the Daily 8 + 21EMAs and can effectuate a Bullish Crossover to squeeze higher as long as MMs allow it. The broader market is still heavy, but pockets of relative strength can exist. Perhaps $ASTS will be one of those moving forward.
Ch🅰️rtradamus 🔋 tweet media
Ch🅰️rtradamus 🔋@Chartradamus

No major changes to the $ASTS chart as of yet. Holding firm for now as it attempts a higher low to initiate MW5 of PW5 to complete LT Wave 3. It does not want to lose $82, and beyond that, the range of $71-$76. This will open a whole new can of worms and facilitate early onset of LT Wave 4. With the recent outperformance of $PL after a stellar earnings and SpaceX IPO on the horizon, it is clear the space basket has continued interest. However, $RKLB appears heavier than $ASTS and $PL. I still contend that $RKLB wants to visit ~$50, roughly 25-30% lower from current levels. It is known that algorithms love to trade these names altogether. It brings into question the direction $ASTS wants to move going forward. Do these companies finally diverge in price action? We can only wait and see.

English
2
10
106
12.6K
Tim
Tim@tim_pscl·
@topsecretstocks What‘s the best company in the ev sector if you had to pick?
English
1
0
1
881
TopSecretStocks 🤫
TopSecretStocks 🤫@topsecretstocks·
Always buy the best company of each sector 👇 Lynk ❌ $ASTS ✅ $RDW ❌ $RKLB ✅ $BKSY ❌ $PL ✅ $TDOC ❌ $HIMS ✅ $CHYM ❌ $SOFI ✅ $TTD ❌ $ZETA ✅ $STNE ❌ $NU ✅ $UPST ❌ $PGY ✅ $SE ❌ $GRAB ✅ $ADYEN ❌ $DLO ✅ $UNH ❌ $CLOV / $OSCR ✅ $BLCO ❌ $HROW ✅ $CRWV ❌ $NBIS ✅ $SEDG ❌ $TE ✅ $ENVX ❌ $QS ✅ $LCID ❌ $TSLA ✅ ...
English
3
26
150
25.5K
Tim
Tim@tim_pscl·
@TradeCycles What do you think about $RKLB and $KRKNF
English
0
0
1
571
Tim retweetet
The Long Investor
The Long Investor@TheLongInvest·
$NBIS Very nice breakout, a retest of the breakout level will give you the perfect entry now
The Long Investor tweet media
English
17
26
253
29.8K
Tim retweetet
The Long Investor
The Long Investor@TheLongInvest·
$SPY is below the 200 Day MA but still managing to stay above the 50 WMA at $645 This is the last line of defence for me, if this is lost then the 200 WMA at the 0.38 fib at $515 is the next target and this is a Market Correction. Time is ticking now to end the War.
The Long Investor tweet media
English
26
40
315
33K
Tim
Tim@tim_pscl·
@topsecretstocks do you think $ZETA will revisit 13$ before pumping?
English
1
0
4
456
TopSecretStocks 🤫
TopSecretStocks 🤫@topsecretstocks·
So many great buying opportunities 🚀
English
4
0
20
3.2K
Nicole Josephine
Nicole Josephine@PolarizingLit·
Allah Akbar !!!!! Don’t forget Fresenius updated their ownership …. $huma $fms partnered stocktitan.net/sec-filings/HU…
Nicole Josephine tweet mediaNicole Josephine tweet mediaNicole Josephine tweet media
Humacyte@humacyte

Humacyte® has received a minimum $1.475M purchase commitment for our Symvess® acellular tissue–engineered vessel-tyod to support a clinical evaluation and outreach program in the Kingdom of Saudi Arabia. This program will help expand awareness of Symvess among healthcare providers across KSA as we continue discussions on establishing a joint venture and commercialization license in the region. This is another important step in our global expansion efforts and we look forward to supporting medical teams as they evaluate the potential of Symvess to improve patient care. For more details read the full press release here: 🔗 bit.ly/3PGVQiZ #Humacyte #Symvess #Biotechnology #GlobalHealth #TissueEngineering #RegenerativeMedicine #MedicalInnovation #ATEV #Innovation PLEASE SEE IMPORTANT SAFETY INFORMATION INCLUDING THE BOXED WARNING, AND FULL PRESCRIBING INFORMATION at bit.ly/4dl5tuL INDICATION SYMVESS is an acellular tissue engineered vessel indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, and autologous vein graft is not feasible. GRAFT FAILURE: loss of SYMVESS integrity due to mid-graft rupture or anastomotic failure can result in life threatening hemorrhage. DO NOT use SYMVESS in patients who have a medical condition that would preclude long-term antiplatelet therapy after acute injury resolution. WARNINGS AND PRECAUTIONS: Vascular Graft Rupture, Anastomotic Failure, and Thrombosis have occurred in patients treated with SYMVESS. SYMVESS is manufactured using cells and reagents that may transmit infectious diseases or agents; none have been reported during clinical testing. ADVERSE REACTIONS: most common (≥3%): thrombosis, fever, pain, anastomotic stenosis, rupture or anastomotic failure, and infection. Trademarks are property of Humacyte Global, Inc © 2026 Humacyte Global Inc. All Rights Reserved.

English
5
0
10
2.4K
Tim retweetet
The Analyst
The Analyst@MMatters22596·
Cyclical investing, simplified: 1. Buy in the pain. 2. Log out. 3. Come back in 3 years. 4 stocks with 200%+ potential (if bought in the right zones): $NVO → $110+ $PYPL → $140+ $NKE → $160+ $TEAM → $230+
The Analyst tweet mediaThe Analyst tweet mediaThe Analyst tweet mediaThe Analyst tweet media
English
16
22
205
17.3K
Tim retweetet
Ch🅰️rtradamus 🔋
Ch🅰️rtradamus 🔋@Chartradamus·
$ONDS LT Wave 3 PT = $27 🟢 Base Case The Ondas chart is experiencing a key battle between bulls and bears here. There are two outcomes possible as it is simultaneously experiencing a Bull Flag breakout and Bear Flag breakdown as it attempts to mark a low for LT Wave 2. My targeted retracement for this correction has been $7-$8 since January and I maintain this stance. My bias leans bearish at this time and I find a test of the Daily 200MA ($7) is in order. However, this will only be confirmed if the stock loses the $9 handle. Otherwise we may simply be in Minor Wave 2 of Primary Wave 1 of LT Wave 3. In that case,
Ch🅰️rtradamus 🔋 tweet mediaCh🅰️rtradamus 🔋 tweet media
English
4
3
19
3K
Tim retweetet
Serenity
Serenity@aleabitoreddit·
< $SIVE | $SIVEF > at a ~$250M valuation looks like one of the most severe structural mispricing in the optical semi market. $LITE and $COHR, have $45B+ valuations today: Largely because of their control over EMLs and VCSELs that they ship to -> InnoLight and Eoptolink. For current pluggable transceiver supercycles. I will keep hammering this home until markets understand: Sivers has replicated this exact, highly lucrative merchant-supplier model for the next paradigm: -> CPO and ELS. And also: -> Lasers that a massive manufacturer like Jabil is using for the current 1.6T upgrade cycle. Sivers saw architectures shifting away from EML and became the pure play supplier for CW. Current Cycle (Pluggables): LITE/COHR supply EML -> InnoLight/Eoptolink build modules -> $GOOGL, $META, $MSFT, $AMZN buy them. Next Cycle (CPO / ELS): Sivers supplies CW DFB -> $POET, Ayar Labs -> flows to hyperscalers like $AMZN, $META, $MSFT and others. However, instead of building up mega fabs with yield/capacity ramp risk: They transitioned to an outsourced, fabless model for high-volume CW Lasers with Win Semi and effectively de-risked scaling. So why does it have a $250M valuation during the photonics supercycle? My opinion: 1. Nobody knows about it yet. 2. Many fund mandates prevents them from buying small caps in Sweden However, when you start looking at obscure upstream names in hyperscaler light supply chain: At the top for the light source sits $SIVE. A small $250M company among $MTSI, $LITE, $COHR, Sumitomo and the $10B-$40B+ incumbents. Again... A $250M company: Powers Jabil's 1.6T LRO optical transceivers modules. Jabil is massive. As well as Ayar, $POET, Enablence/ $ONET and many other names now (that are not disclosed) for diversification. $SIVE found their way to scale as the lightsource of hyperscaler supply chains for future photonic architectures. And looks incredibly undervalued, relative to forward TAM expansion and ramp.
Serenity tweet media
English
72
90
742
122.8K
Tim retweetet
Echo Analysis
Echo Analysis@EchoAnalysis·
All you need is: Fibonacci Moving averages RSI MACD Elliott waves Control over your emotions Combine all of these and you will do extraordinary things.
English
4
5
42
3.1K
Tim
Tim@tim_pscl·
@YodaStockInvest sad to see u are right lmao holding as well🫩
English
1
0
1
139
YodaStocks
YodaStocks@YodaStockInvest·
$SOFI is a shit stock… Not a garbage company though, I’ll keep holding! Down since IPO, while fundamentals are going up rapidly.
YodaStocks tweet media
English
22
0
76
8.7K